Table 2

Incidence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM) during the five years follow-up after hospitalisation

Hyperglycaemia group

Normoglycaemia group

Relative risk


Finished follow-up

- sepsisa

70

139

- ACSb

75

153

- other diagnoses

48

106

all patients

193

398

New IFG or IGT

- sepsisa

18

18

2.1 (95% CI 1.3 to 4.1)

- ACSb

19

17

2.6 (95% CI 1.4 to 4.6)

- other diagnoses

10

14

1.9 (95% CI 0.9 to 3.9)

all patients

47 (24.4%)

49 (12.3%)

2.3 (95% CI 1.6 to 3.4)

New Type 2 DM

- sepsisa

13

6

5.0 (95% CI 2.0 to 12.5)

- ACSb

10

4

6.0 (95% CI 1.9 to 18.5)

- other diagnoses

10

4

6.0 (95% CI 2.0 to 18.1)

all patients

33 (17.1%)

14 (3.5%)

5.6 (95% CI 3.1 to 10.2)

Remained normoglycaemic

- sepsisa

39

115

- ACSb

46

132

- other diagnoses

28

88

all patients

113 (58.5%)

335 (84.2%)


a includes severe sepsis and septic shock

b ACS, acute coronary syndrome (unstable angina and myocardial infarction

Gornik et al. Critical Care 2010 14:R130   doi:10.1186/cc9101

Open Data